Accelr8 Shares Rise on Data Presentation | GenomeWeb

NEW YORK (GenomeWeb News) – Shares of Accelr8 Technology rose 51 percent in Thursday afternoon trade after the firm issued a release saying it had presented results on its rapid tests for identifying multi-resistant organisms at the recent 109th General Meeting of the American Society for Microbiology.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.